Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud’s phenomenon-Reference-Cited by-同舟云学术

Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud’s phenomenon

Published:2021-06-16 Issue:6 Volume:50 Page:479-484
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Herrick AL¹,Heal C²,Wilkinson J²,Dinsdale G¹,Manning J¹,Gunnarsson K³,Jakobsson P-J³,Murray A¹

Affiliation:

1. Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

2. Centre for Biostatistics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK

3. Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Funder

Gesynta Pharma

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2021.1907926

Reference15 articles.

1. Raynaud’s phenomenon

2. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey

3. Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception

4. Design and Reporting of Randomised Controlled Trials for Raynaud’s Phenomenon

5. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Experimental Phototherapy Device for Studying the Effects of Blue Light on Patients with Raynaud’s Phenomenon;Annals of Biomedical Engineering;2024-03-26

2. A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's;Rheumatology;2024-01-30

3. Practical Approach to the Patient with Raynaud’s Phenomenon: Primary Versus Secondary Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024

4. Statistical Design and Reporting of Randomised Controlled Trials for Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024

5. Assessment of digital perfusion as a surrogate outcome in Raynaud’s phenomenon clinical trials;Rheumatology;2023-07-08